Renaissance Pharmaceuticals Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Renaissance Pharmaceuticals's estimated annual revenue is currently $19.5M per year.(i)
  • Renaissance Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Renaissance Pharmaceuticals has 97 Employees.(i)
  • Renaissance Pharmaceuticals grew their employee count by -8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.5M52-2%N/AN/A
#2
$354.3M461-2%$567.1MN/A
#3
$379.5M1888-6%N/AN/A
#4
$6.8M34-6%N/AN/A
#5
$5.4M270%N/AN/A
#6
$39.4M19615%N/AN/A
#7
$37.4M186-6%N/AN/A
#8
$7M353%N/AN/A
#9
$13.5M67-11%N/AN/A
#10
$10.9M540%N/AN/A
Add Company

Renaissance Pharmaceuticals is a pharmaceuticals company based out of 17 Battery Pl Rm 306, New York, New York, United States.

keywords:N/A

N/A

Total Funding

97

Number of Employees

$19.5M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Renaissance Pharmaceuticals News

2022-04-20 - Brokerages Anticipate NeuroBo Pharmaceuticals, Inc ...

Equities research analysts expect NeuroBo Pharmaceuticals, ... Renaissance Technologies LLC acquired a new stake in shares of NeuroBo...

2022-04-20 - Diffusion Pharmaceuticals (DFFN) – Investment Analysts ...

Renaissance Technologies LLC now owns 1,223,102 shares of the company's stock valued at $373,000 after acquiring an additional 97,600 shares...

2022-04-17 - Quoin Pharmaceuticals Ltd (NASDAQ:QNRX) Sees Significant ...

Renaissance Technologies LLC owned approximately 8.53% of Quoin Pharmaceuticals as of its most recent filing with the Securities & Exchange...

2019-09-03 - Migraine biotech Satsuma Pharmaceuticals sets terms for $75 ...

Satsuma Pharmaceuticals, a clinical-stage biotech developing a therapy for ... Renaissance Capital's Renaissance IPO ETF (symbol: IPO) ...

2019-09-03 - Digging Up the Details on Pieris Pharmaceuticals, Inc. (PIRS)

On Friday, shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) marked ... In the meanwhile, Renaissance Technologies LLC also increased ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.8M9711%N/A
#2
$12.6M97-3%$13.8M
#3
$14.1M972%$97.4M
#4
$22.1M979%$34.4M
#5
$17.5M9721%N/A

Renaissance Pharmaceuticals Executives


NameTitle
Daniel BrennanVice President, Quality